NOT-DK-19-008: NIDDK Will Participate in RFA-OD-19-012: Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trial Not Allowed)

NIDDK Will Participate in RFA-OD-19-012: Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trial Not Allowed)

Notice Number: NOT-DK-19-008

Key Dates
Release Date: December 18, 2018

Related Announcements
RFA-OD-19-012

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is participating in RFA-OD-19-012 "Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trial Not Allowed)" effective immediately. The following sections of RFA-OD-19-012 have been updated (shown in italics) to reflect the participation of NIDDK in this Funding Opportunity Announcement.

Part 1. Overview Information

Components of Participating Organizations

Office of the Behavioral and Social Sciences Research (OBSSR)

National Cancer Institute (NCI)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute on Drug Abuse (NIDA)

National Institute of Environmental Health Sciences (NIEHS)

National Institute of Mental Health (NIMHD)

National Center for Complementary and Integrative Health (NCCIH)

National Heart, Lung, and Blood Institute (NHLBI)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. OBSSR and the following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)

Catalog of Federal Domestic Assistance (CFDA) Number(s) 93.242, 93.213, 93.121, 93.865, 93.398, 93.279, 93.113, 93.847

Part 2. Section I. Funding Opportunity Description - Areas of Interest of Participating Institutes, Centers and Offices is amended to include the NIDDK interest statement below:

NIDDK: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will only accept applications that are highly relevant to the NIDDK mission, which is to conduct and support medical research and research training and to disseminate science-based information on diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases, to improve people's health and quality of life.

Section VII. Agency Contacts

Scientific/Research Contact(s)

Pamela L. Thornton, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-480-6476
Email: [email protected]

Financial/Grants Management Contact(s)

Todd Le
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-7794
Email: [email protected]

All other aspects of this Funding Opportunity Announcement remain the same.

Inquiries

Please direct all inquiries to:

Pamela L. Thornton, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-480-6476
Email: [email protected]